Skip to main content
. 2020 Mar 16;2(1):vdaa038. doi: 10.1093/noajnl/vdaa038

Figure 2.

Figure 2.

Waterfall plot demonstrating the intracranial response to bevacizumab-based treatment in patients with recurrent BM on T1 CE (after Gd-contrast enhancement) and T2/FLAIR MRI images. FLAIR sequence or if not available T2 sequence was used for response assessment. The best clinical response for each patient is given below. SD, stable disease; PR, partial response; PD, progressive disease.